v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (Unaudited) - USD ($)
$ in Thousands
Total
At-the-market Offering Program
February 2025 Offering [Member]
Common Stock
Class A Common Stock
Common Stock
Class A Common Stock
At-the-market Offering Program
Common Stock
Class A Common Stock
February 2025 Offering [Member]
Common Stock
Class B Common Stock
Additional Paid-in Capital
Additional Paid-in Capital
At-the-market Offering Program
Additional Paid-in Capital
February 2025 Offering [Member]
Accumulated Deficit
Balance at Dec. 31, 2024 $ 49,040     $ 5     $ 2 $ 343,475     $ (294,442)
Balance (in shares) at Dec. 31, 2024       58,076,261     15,055,288        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Net loss (9,418)                   (9,418)
Issuance of restricted stock, net (in shares)       29,135              
Issuance of Class A common stock upon exercise of stock options 33             33      
Issuance of Class A common stock upon exercise of stock options (in shares)       41,390              
Issuance of common stock   $ 129             $ 129    
Issuance of common stock (in shares)         126,398            
Issuance of common stock and warrants, net of offering costs     $ 2,385     $ 1       $ 2,384  
Issuance of common stock and warrants, net of offering costs (in shares)           4,511,278          
Issuance of common stock in connection with warrant exercise (in shares)       100              
Stock-based compensation expense 945             945      
Balance at Mar. 31, 2025 43,114     $ 6     $ 2 346,966     (303,860)
Balance (in shares) at Mar. 31, 2025       62,784,562     15,055,288        
Balance at Dec. 31, 2024 49,040     $ 5     $ 2 343,475     (294,442)
Balance (in shares) at Dec. 31, 2024       58,076,261     15,055,288        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Net loss (18,643)                    
Balance at Jun. 30, 2025 35,126     $ 6     $ 2 348,203     (313,085)
Balance (in shares) at Jun. 30, 2025       63,525,713     15,055,288        
Balance at Mar. 31, 2025 43,114     $ 6     $ 2 346,966     (303,860)
Balance (in shares) at Mar. 31, 2025       62,784,562     15,055,288        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Net loss (9,225)                   (9,225)
Issuance of restricted stock, net (in shares)       26,608              
Issuance of Class A common stock upon exercise of stock options 4             4      
Issuance of Class A common stock upon exercise of stock options (in shares)       32,750              
Issuance of common stock   686             686    
Issuance of common stock (in shares)         681,793            
Stock-based compensation expense 547             547      
Balance at Jun. 30, 2025 35,126     $ 6     $ 2 348,203     (313,085)
Balance (in shares) at Jun. 30, 2025       63,525,713     15,055,288        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Issuance of common stock (in shares)         7,809,779            
Balance at Jun. 30, 2026 36,758     $ 9     $ 2 384,684     (347,937)
Balance (in shares) at Jun. 30, 2026       90,987,381     15,055,288        
Balance at Dec. 31, 2025 41,005     $ 8     $ 2 371,011     (330,016)
Balance (in shares) at Dec. 31, 2025       82,166,458     15,055,288        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Net loss (8,623)                   (8,623)
Issuance of restricted stock, net (in shares)       575,651              
Issuance of Class A common stock upon exercise of stock options 34             34      
Issuance of Class A common stock upon exercise of stock options (in shares)       44,788              
Issuance of common stock   803             803    
Issuance of common stock (in shares)         678,012            
Issuance of common stock and warrants, net of offering costs 495             495      
Stock-based compensation expense 647             647      
Balance at Mar. 31, 2026 34,361     $ 8     $ 2 372,990     (338,639)
Balance (in shares) at Mar. 31, 2026       83,464,909     15,055,288        
Balance at Dec. 31, 2025 41,005     $ 8     $ 2 371,011     (330,016)
Balance (in shares) at Dec. 31, 2025       82,166,458     15,055,288        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Net loss (17,921)                    
Issuance of common stock (in shares)         7,809,779            
Balance at Jun. 30, 2026 36,758     $ 9     $ 2 384,684     (347,937)
Balance (in shares) at Jun. 30, 2026       90,987,381     15,055,288        
Balance at Mar. 31, 2026 34,361     $ 8     $ 2 372,990     (338,639)
Balance (in shares) at Mar. 31, 2026       83,464,909     15,055,288        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Net loss (9,298)                   (9,298)
Issuance of restricted stock, net (in shares)       187,158              
Issuance of Class A common stock upon exercise of stock options 220             220      
Issuance of Class A common stock upon exercise of stock options (in shares)       203,547              
Issuance of common stock   $ 10,572     $ 1       $ 10,571    
Issuance of common stock (in shares)         7,131,767            
Stock-based compensation expense 903             903      
Balance at Jun. 30, 2026 $ 36,758     $ 9     $ 2 $ 384,684     $ (347,937)
Balance (in shares) at Jun. 30, 2026       90,987,381     15,055,288